A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

The molecular pathology of Alzheimer's disease

Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403

Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type

Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399

Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214

A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease

Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142

Amyloid β-peptide polymerization studied using fluorescence correlation spectroscopy

Tjernberg, L. O., Pramanik, A., Björling, S. C., Thyberg, P., Thyberg, J., Nordstedt, C., Berndt, K. D., Terenius, L. Y., & Rigler, R. W. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80020-9 · Cited by 160

The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase Activities

Klafki, H., Abramowski, D., Swoboda, R., Paganetti, P., & Staufenbiel, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28655 · Cited by 159

Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic Mice

Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1951 · Cited by 158

Nonfibrillar diffuse amyloid deposition due to a gamma42-secretase site mutation points to an essential role for N-truncated Abeta42 in Alzheimer's disease

Kumar-Singh, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2589 · Cited by 158

Recent advances in the modeling of Alzheimer’s disease

Sasaguri, H., Hashimoto, S., Watamura, N., Sato, K., Takamura, R., Nagata, K., Tsubuki, S., Ohshima, T., Yoshiki, A., Sato, K., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.807473 · Cited by 157

Amyloid‐ß‐directed immunotherapy for Alzheimer's disease

Lannfelt, L., Relkin, N. R., & Siemers, E. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12168 · Cited by 161

The Regulatory Functionality of Exosomes Derived from hUMSCs in 3D Culture for Alzheimer's Disease Therapy

Yang, L., Zhai, Y., Hao, Y., Zhu, Z., & Cheng, G. (2019) · Small · doi:10.1002/smll.201906273 · Cited by 157

The molecular and genetic basis of AD: The end of the beginning

Rosenberg, R. N. (2000) · Neurology · doi:10.1212/wnl.54.11.2045 · Cited by 158

Transgenic Drosophila expressing human amyloid precursor protein show γ-secretase activity and a blistered-wing phenotype

Fossgreen, A., Brückner, B., Czech, C., Masters, C. L., Beyreuther, K. T., & Paro, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13703 · Cited by 156

ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site

Hussain, I., Powell, D. J., Howlett, D. R., Chapman, G. A., Gilmour, L., Murdock, P. R., Tew, D. G., Meek, T. D., Chapman, C. G., Schneider, K., et al. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0884 · Cited by 156

Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms

Czech, C., Tremp, G. L., & Pradier, L. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00033-7 · Cited by 160

New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease

Fuller, J. P., Stavenhagen, J. B., & Teeling, J. L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00235 · Cited by 154

High selective expression of α7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques

Yu, W., Guan, Z.-Z., Bogdanović, N., & Nordberg, A. K. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.015 · Cited by 153

Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease

Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 155

The Genetics of the Amyloidoses

Buxbaum, J. N., & Tagoe, C. E. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.543 · Cited by 153

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease

Lannfelt, L., Möller, C., Basun, H., Osswald, G., Sehlin, D., Satlin, A., Logovinsky, V., & Gellerfors, P. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt246 · Cited by 153

Secreted forms of β‐amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons

Mattson, M. P. (1994) · Journal of Neurobiology · doi:10.1002/neu.480250409 · Cited by 156

Histone deacetylases (HDACs) and brain function

Volmar, C.-H., & Wahlestedt, C. (2015) · Neuroepigenetics · doi:10.1016/j.nepig.2014.10.002 · Cited by 151

Butyrylcholinesterase Is Associated With β-Amyloid Plaques in the Transgenic APP SWE /PSEN1dE9 Mouse Model of Alzheimer Disease

Darvesh, S., Cash, M. K., Reid, G. A., Martin, E. V., Mitnitski, A., & Geula, C. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823cc7a6 · Cited by 153

Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice

Yuzwa, S. A., Shan, X., Jones, B. A., Zhao, G., Woodward, M. L., Li, X., Zhu, Y., McEachern, E. J., Silverman, M. A., Watson, N. V., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-42 · Cited by 156

Enhanced Amyloidogenic Processing of the β-Amyloid Precursor Protein in Gene-targeted Mice Bearing the Swedish Familial Alzheimer's Disease Mutations and a “Humanized” Aβ Sequence

Reaume, A. G., Howland, D. S., Trusko, S. P., Savage, M. J., Lang, D. M., Greenberg, B. D., Siman, R., & Scott, R. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23380 · Cited by 150

Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer’s disease mouse model

Herskowitz, J. H., Feng, Y., Mattheyses, A. L., Hales, C. M., Higginbotham, L. A., Duong, D. M., Montine, T. J., Troncoso, J. C., Thambisetty, M., Seyfried, N. T., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2508-13.2013 · Cited by 150

Evidence for an Alzheimer Disease Susceptibility Locus on Chromosome 12 and for Further Locus Heterogeneity

Rogaeva, E. A. (1998) · JAMA · doi:10.1001/jama.280.7.614 · Cited by 150

α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer’s disease

Shea, D. W., Hsu, C.-C., Bi, T., Paranjapye, N., Childers, M. C., Cochran, J., Tomberlin, C., Wang, L., Paris, D., Zonderman, J. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820585116 · Cited by 152

Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways

Wojtas, A., Kang, S. S., Olley, B. M., Gatherer, M., Shinohara, M., Lozano, P. A., Liu, C., Kurti, A., Baker, K. E., Dickson, D. W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701137114 · Cited by 147

Flemish and Dutch Mutations in Amyloid β Precursor Protein Have Different Effects on Amyloid β Secretion

Jonghe, C. D., Zehr, C., Yager, D., Prada, C.-M., Younkin, S. G., Hendriks, L., Broeckhoven, C. V., & Eckman, C. B. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0202 · Cited by 151

Transgenic mouse models of Alzheimer's disease: phenotype and application.

(2003) · PubMed · doi:10.1097/01.fbp.0000088420.18414.ff · Cited by 147

The unfolded protein response and Alzheimer’s disease

Imaizumi, K., Miyoshi, K., Katayama, T., Yoneda, T., Taniguchi, M., Kudo, T., & Tohyama, M. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00049-7 · Cited by 147

If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?

Haass, C., & Selkoe, D. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001694 · Cited by 145

The Alzheimer Disease Protective Mutation A2T Modulates Kinetic and Thermodynamic Properties of Amyloid-β (Aβ) Aggregation

Benilova, I., Gallardo, R. U., Ungureanu, A.-A., Cano, V. C., Snellinx, A., Ramakers, M., Bartic, C., Rousseau, F., Schymkowitz, J. W. H., & Strooper, B. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.599027 · Cited by 151

Genomics of Alzheimer Disease

Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0301 · Cited by 149

CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics

Bhardwaj, S., Kesari, K. K., Rachamalla, M., Mani, S., Ashraf, G. M., Jha, S. K., Kumar, P., Ambasta, R. K., Dureja, H., Devkota, H. P., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.001 · Cited by 145

Physiology and pharmacology of amyloid precursor protein

Cho, Y., Bae, H., Okun, E., Arumugam, T. V., & Jo, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108122 · Cited by 150

Evidence for phosphorylation and oligomeric assembly of presenilin 1

Seeger, M., Nordstedt, C., Petanceska, S. S., Kovacs, D. M., Gouras, G. K., Hahne, S., Fraser, P., Lévesque, L., Czernik, A. J., George‐Hyslop, P. S., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5090 · Cited by 146

Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease

Wakutani, Y. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.010611 · Cited by 145

Sumoylation and human disease pathogenesis

Sarge, K. D., & Park-Sarge, O.-K. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.01.004 · Cited by 148

Amyloid‐induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue‐culture models

Götz, J., Schild, A., Hoerndli, F. J., & Pennanen, L. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.013 · Cited by 146

Overview of Transgenic Mouse Models for Alzheimer's Disease

Myers, A., & McGonigle, P. (2019) · Current Protocols in Neuroscience · doi:10.1002/cpns.81 · Cited by 148

Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation

Johnston, J. A., Cowburn, R. F., Norgren, S., Wiehager, B., Venizelos, N., Winblad, B. G., Vigo‐Pelfrey, C., Schenk, D., Lannfelt, L., & O’Neill, C. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01137-0 · Cited by 144

Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases

Barelli, H., Lebeau, A., Vizzavona, J., Delaère, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J. D., Khorkova, O., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401708 · Cited by 143

Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons

Tienari, P. J., Ida, N., Ikonen, E., Simons, M., Weidemann, A., Multhaup, G., Masters, C. L., Dotti, C. G., & Beyreuther, K. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4125 · Cited by 138

Twenty years of Alzheimer’s disease‐causing mutations

Goate, A., & Hardy, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07575.x · Cited by 141

In Vivo Effects of ApoE and Clusterin on Amyloid-β Metabolism and Neuropathology

Holtzman, D. M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:247 · Cited by 139

X11 Interaction with β-Amyloid Precursor Protein Modulates Its Cellular Stabilization and Reduces Amyloid β-Protein Secretion

Sastre, M., Turner, R. S., & Levy, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22351 · Cited by 136

Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis

Boche, D., Denham, N., Holmes, C., & Nicoll, J. A. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0719-5 · Cited by 135

Making the final cut: Pathogenic amyloid-β peptide generation by γ-secretase

Steiner, H., Fukumori, A., Tagami, S., & Okochi, M. (2018) · Cell Stress · doi:10.15698/cst2018.11.162 · Cited by 133

Animal models of Alzheimer disease: historical pitfalls and a path forward

Cavanaugh, S. E. (2014) · ALTEX · doi:10.14573/altex.1310071 · Cited by 132

CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS

Price, D. L., & Sisodia, S. S. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.435 · Cited by 132

The Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease

MacLeod, R., Hillert, E., Cameron, R. T., & Baillie, G. S. (2015) · Future Science OA · doi:10.4155/fso.15.9 · Cited by 136

Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits

Miller, E. C., Teravskis, P. J., Dummer, B. W., Zhao, X., Huganir, R. L., & Liao, D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12507 · Cited by 131

BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis

Zhang, S., Wang, Z., Cai, F., Zhang, M., Wu, Y., Zhang, J., & Song, W. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0340-17.2017 · Cited by 133

The beta‐amyloid domain is essential for axonal sorting of amyloid precursor protein.

Tienari, P. J., Strooper, B. D., Ikonen, E., Simons, M., Weidemann, A., Czech, C., Hartmann, T., Ida, N., Multhaup, G., Masters, C. L., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00907.x · Cited by 131

An Alzheimer's Disease-Linked PS1 Variant Rescues the Developmental Abnormalities of PS1-Deficient Embryos

Davis, J. A., Naruse, S., Chen, H., Eckman, C., Younkin, S. G., Price, D. L., Borchelt, D., Sisodia, S. S., & Wong, P. C. (1998) · Neuron · doi:10.1016/s0896-6273(00)80998-8 · Cited by 131

Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation

Lalonde, R., Dumont, M., Staufenbiel, M., Sturchler, C., & Strazielle, C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03476-5 · Cited by 135

Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cells

Deng, G., Pike, C. J., & Cotman, C. W. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01142-8 · Cited by 130

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease

Maia, M., & Sousa, E. (2019) · Pharmaceuticals · doi:10.3390/ph12010041 · Cited by 134

Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals.

Haass, C., Koo, E. H., Capell, A., Teplow, D. B., & Selkoe, D. J. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.4.537 · Cited by 131

Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice

Lamb, B. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1535 · Cited by 128

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain

Gómez‐Isla, T., Growdon, W. B., McNamara, M. J., Nochlin, D., Bird, T. D., Arango, J. C., Lopera, F., Kosik, K. S., Lantos, P. L., Cairns, N. J., et al. (1999) · Brain · doi:10.1093/brain/122.9.1709 · Cited by 131

Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D

Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., & Krafft, G. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32325-6 · Cited by 128

BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions

Hu, X., Das, B., Hou, H., He, W., & Yan, R. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171831 · Cited by 129

BACE1 and BACE2 enzymatic activities in Alzheimer’s disease

Ahmed, R. R., Holler, C. J., Webb, R. L., Li, F., Beckett, T. L., & Murphy, M. P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06528.x · Cited by 133

Alzheimer disease: Amyloidogenesis, the presenilins and animal models

Newman, M., Musgrave, I., & Lardelli, M. T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.001 · Cited by 129

Interaction between genetic and environmental risk factors for Alzheimer's disease: A reanalysis of case‐control studies

van Duijn, C. M., Clayton, D. G., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., et al. (1994) · Genetic Epidemiology · doi:10.1002/gepi.1370110609 · Cited by 129

Targeting Presenilin-type Aspartic Protease Signal Peptide Peptidase with γ-Secretase Inhibitors

Weihofen, A., Lemberg, M. K., Friedmann, E., Rueeger, H., Schmitz, A., Paganetti, P., Rovelli, G., & Martoglio, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301372200 · Cited by 126

Enhanced Release of Amyloid -Protein from Codon 670/671 Swedish Mutant -Amyloid Precursor Protein Occurs in Both Secretory and Endocytic Pathways

Perez, R. G., Squazzo, S. L., & Koo, E. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.9100 · Cited by 126

Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice

Wirths, O., Multhaup, G., Czech, C., Feldmann, N., Blanchard, V., Tremp, G., Beyreuther, K., Pradier, L., & Bayer, T. A. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00442.x · Cited by 125

Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion

Barbero-Camps, E., Roca-Agujetas, V., Bartolessis, I., de Dios, C., Fernández-Checa, J. C., Marí, M., Morales, A., Hartmann, T., & Colell, A. (2018) · Autophagy · doi:10.1080/15548627.2018.1438807 · Cited by 125

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Xia, D., Lianoglou, S., Sandmann, T., Calvert, M., Suh, J. H., Thomsen, E., Dugas, J., Pizzo, M. E., DeVos, S. L., Earr, T. K., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00547-7 · Cited by 124

Increased plasma beta-secretase 1 may predict conversion to Alzheimer’s disease dementia in individuals with mild cognitive impairment

Shen, Y., Wang, H., Sun, Q., Yao, H., Keegan, A. P., Mullan, M., Wilson, J., Lista, S., Leyhe, T., Laske, C., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.007 · Cited by 123

Alzheimer’s disease due to loss of function: A new synthesis of the available data

Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123

The Pro Domain of β-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain

Shi, X., Chen, E., Yin, K., Sang, N., Garsky, V. M., Lai, M., Li, Y., Platchek, M., Register, R. B., Sardana, M. K., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009200200 · Cited by 123

Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease

Gurney, M. E., D'Amato, E. C., & Burgin, A. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0309-7 · Cited by 121

Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease

Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121

Alzheimer's Disease and the Amyloid β-Protein

Walsh, D. M., & Teplow, D. B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00012-6 · Cited by 121

Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities

Reitz, C. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1002469 · Cited by 125

Sumoylation of amyloid precursor protein negatively regulates Aβ aggregate levels

Zhang, Y.-Q., & Sarge, K. D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.109 · Cited by 119

Untitled work

(2008) · doi:10.1074/jbc.m801487200 · Cited by 105

Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau

Rayaprolu, S., Higginbotham, L., Bagchi, P., Watson, C. M., Zhang, T., Levey, A. I., Rangaraju, S., & Seyfried, N. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00840-3 · Cited by 118

Diseases of the nERVous system: retrotransposon activity in neurodegenerative disease

Tam, O. H., Ostrow, L. W., & Hammell, M. (2019) · Mobile DNA · doi:10.1186/s13100-019-0176-1 · Cited by 127

cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein

Bressler, S. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1589 · Cited by 117

Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase.

Roberts, S. B., Ripellino, J. A., Ingalls, K. M., Robakis, N. K. R. K., & Felsenstein, K. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42055-2 · Cited by 120

Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease

Basun, H., Bogdanovic, N., Ingelsson, M., Almkvist, O., Näslund, J., Axelman, K., Bird, T. D., Nochlin, D., Schellenberg, G. D., Wahlund, L.-O., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.499 · Cited by 115

Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer’s Disease

Bezzina, C., Verret, L., Juan, C., Remaud, J., Halley, H., Rampon, C., & Dahan, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119910 · Cited by 121

Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo

Klyubin, I. V., Walsh, D. M., Cullen, W. K., Fadeeva, J. V., Anwyl, R., Selkoe, D. J., & Rowan, M. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03389.x · Cited by 121

β-Amyloid Modulation of Synaptic Transmission and Plasticity

Venkitaramani, D. V., Chin, J., Netzer, W. J., Gouras, G. K., Lesné, S., Malinow, R., & Lombroso, P. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3478-07.2007 · Cited by 118

Cell-type and Amyloid Precursor Protein-type Specific Inhibition of Aβ Release by Bafilomycin A1, a Selective Inhibitor of Vacuolar ATPases

Knops, J., Suomensaari, S., Lee, M., McConlogue, L., Seubert, P. A., & Sinha, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2419 · Cited by 118

GSK3β Activity Modifies the Localization and Function of Presenilin 1

Uemura, K., Kuzuya, A., Shimozono, Y., Aoyagi, N., Andō, K., Shimohama, S., & Kinoshita, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610708200 · Cited by 117

Dense-Core Senile Plaques in the Flemish Variant of Alzheimer's Disease Are Vasocentric

Kumar-Singh, S., Cras, P., Wang, R., Kros, J. M., van Swieten, J., Lübke, U., Ceuterick, C., Serneels, S., Vennekens, K., Timmermans, J.-P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64207-1 · Cited by 114

Insights into Alzheimer disease pathogenesis from studies in transgenic animal models

Schaeffer, E. L., Figueiró, M., & Gattaz, W. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300006 · Cited by 114

Transgenic mice expressing the βAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination

Lalonde, R., Lewis, T. L., Strazielle, C., Kim, H., & Fukuchi, K.-I. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02694-5 · Cited by 113

Apolipoprotein E, Amyloid, and Alzheimer Disease

Bales, K. R. (2002) · Molecular Interventions · doi:10.1124/mi.2.6.363 · Cited by 114

Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis

Sheppard, O., & Coleman, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch1 · Cited by 127

The Cysteine Protease Inhibitor, E64d, Reduces Brain Amyloid-β and Improves Memory Deficits in Alzheimer's Disease Animal Models by Inhibiting Cathepsin B, but not BACE1, β-Secretase Activity

Hook, G., HOOK, V. Y. H., & Kindy, M. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110101 · Cited by 114

Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110

Targeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease

Mango, D., Saidi, A., Cisale, G. Y., Feligioni, M., Corbo, M., & Nisticò, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00778 · Cited by 114

Pharmacogenomics in Alzheimer's Disease

Cacabelos, R. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-205-2_10 · Cited by 109

Fatty acids, lipid metabolism and Alzheimer pathology

Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 115

The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease

Campion, D., Martin, C., Heilig, R., Charbonnier, F., Moreau, V., Flaman, J., Petit, J., Hannequin, D., Brice, A., & Frébourg, T. (1995) · Genomics · doi:10.1016/0888-7543(95)80208-4 · Cited by 112

Amyloid‐β protein (Aβ) Glu11 is the major β‐secretase site of β‐site amyloid‐β precursor protein‐cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis

Deng, Y., Wang, Z., Wang, R., Zhang, X., Zhang, S., Wu, Y., Staufenbiel, M., Cai, F., & Song, W. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12235 · Cited by 108

Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214

Low frequency of the APP670/671 mutation in familial Alzheimer's disease in Sweden

Lannfelt, L., Viitanen, M. H., Johansson, K., Axelman, K., Lilius, L., Almqvist, E. W., & Winblad, B. G. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90083-w · Cited by 17

Sequencing of exons 16 and 17 of the β-amyloid precursor protein gene in 14 families with early onset Alzheimer's disease fails to reveal mutations in the β-amyloid sequence

Crawford, F., Hardy, J., Mullan, M., Goate, A., Hughes, D. J., Fidani, L., Roques, P. K., Rossor, M. N., & Chartier‐Harlin, M. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90042-r · Cited by 42

EARLY-ONSET ALZHEIMERS-DISEASE CAUSED BY MUTATIONS AT CODON-717 OF THE BETA-AMYLOID PRECURSOR PROTEIN GENE

CHARTIERHARLIN, M., CRAWFORD, F., Houlden, H., WARREN, A., Hughes, D., FIDANI, L., Goate, A., Rossor, M. N., Roques, P. K., Hardy, J., et al. (1991) · UCL Discovery (University College London) · Cited by 23

Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β‐amyloid precursor protein gene

Karlinsky, H., Vaula, G., Haines, J. L., Ridgley, J., Bergeron, C., Mortilla, M., Tupler, R. G., Percy, M. E., Robitaille, Y., Noldy, N. E., et al. (1992) · Neurology · doi:10.1212/wnl.42.8.1445 · Cited by 123